R. Yuan

In vivo drug‐drug interaction studies‐ A survey of all new molecular entities approved from 1987 to 1997

L. Lesko, P. Marroum, R. Uppoor, 2000, Clinical pharmacology and therapeutics.

A comparative study of allometric scaling with plasma concentrations predicted by species‐invariant time methods

R. Yuan, I. Mahmood, 1999, Biopharmaceutics & drug disposition.

Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.

R. Yuan, J. Venitz, 2000, International journal of clinical pharmacology and therapeutics.

Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.

Shiew-Mei Huang, R. Yuan, K. Reynolds, 2002, Drug metabolism and disposition: the biological fate of chemicals.

FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on Labeling

Shiew-Mei Huang, L. Lesko, F. Ajayi, 1999, Journal of clinical pharmacology.

Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and Triazolam

R. Yuan, J. Balian, D. Flockhart, 1999, Journal of clinical pharmacology.

Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo.

L. Benet, R. Yuan, M. Sumi, 1997, The Journal of pharmacology and experimental therapeutics.

In vitro metabolic interaction studies: Experience of the Food and Drug Administration

Patrick Marroum, L. Lesko, P. Marroum, 1999, Clinical pharmacology and therapeutics.